Cytosorbents CTSO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.64 | 92.30 | -0.09 | -4,385 | -5 | |
| 2025Q3 | 0.93 | 97.81 | -0.05 | -2,862 | -3 | |
| 2025Q2 | 1.28 | -141.05 | 0.03 | -3,615 | 2 | |
| 2025Q1 | 1.00 | 445.25 | -0.02 | -3,887 | -1 | |
| 2024Q4 | 0.91 | 43.19 | -0.14 | -3,729 | -8 | |
| 2024Q3 | 1.50 | 242.17 | -0.05 | -4,514 | -2 | |
| 2024Q2 | 0.70 | 87.15 | -0.08 | -3,688 | -4 | |
| 2024Q1 | 0.95 | 77.55 | -0.11 | -4,926 | -6 | |
| 2023Q4 | 1.11 | 141.62 | -0.13 | -9,341 | -6 | |
| 2023Q3 | 1.88 | 80.97 | -0.21 | -7,417 | -9 | |
| 2023Q2 | 3.59 | 106.75 | -0.14 | -6,559 | -6 | |
| 2023Q1 | 3.37 | 108.66 | -0.17 | -7,892 | -7 | |
| 2022Q4 | 1.55 | 332.43 | -0.01 | -6,356 | -1 | |
| 2022Q3 | 1.36 | 73.63 | -0.28 | -9,017 | -12 | |
| 2022Q2 | 2.19 | 76.65 | -0.25 | -8,357 | -11 | |
| 2022Q1 | 3.19 | 86.82 | -0.21 | -7,791 | -9 | |
| 2021Q4 | 4.19 | 95.10 | -0.22 | -9,562 | -9 | |
| 2021Q3 | 8.12 | 84.22 | -0.15 | -5,406 | -6 | |
| 2021Q2 | 7.55 | 104.99 | -0.10 | -4,925 | -5 | |
| 2021Q1 | 8.68 | 68.59 | -0.10 | -2,852 | -4 |